Effects of heparin on renal morphology and albuminuria in experimental diabetes

American Journal of Physiology - Endocrinology and Metabolism

Volumn 271, Issue 2 34-2, 1996, Pages

  Marshall, Sally M ^a,b   Hansen, Klavs W ^a   Østerby, Ruth ^a   Frystyk, Jan ^a   Ørskov, Hans ^a   Flyvbjerg, Allan ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

albumin excretion; diabetic glomerulopathy; renal histology

Indexed keywords

ALBUMIN; CREATININE; FRUCTOSAMINE; GLYCOSYLATED HEMOGLOBIN; HEPARIN; POTASSIUM ION; SODIUM ION;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; FEMALE; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS CAPILLARY; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; HEPARINIZATION; KIDNEY MASS; MESANGIUM; NONHUMAN; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; RAT; SODIUM URINE LEVEL; STREPTOZOCIN DIABETES; URINARY EXCRETION;

EID: 0029784058     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.271.2.e326     Document Type: Article

References (30)

1. Adler, S., and B. Eng. Reversal of inhibition of rat glomerular epithelial cell growth by growth factors. Am. J. Pathol. 136: 557-563, 1990.
2. Barzu, T., J.-M. Herbert, A. Desmouliere, P. Carayon, and M. Pascal. Characterisation of rat aortic smooth muscle cells resistant to the antiproliferative activity of heparin following long-term heparin treatment. J. Cell. Physiol. 160: 239-248, 1994.
3. Boye, N,. and J. Ingerslev. Rapid and inexpensive microdetermination of serum fructosamine results in diabetics, uraemics, diabetics with uraemia and healthy subjects. Scand. J. Lab. Invest. 48: 779-783, 1988.
4. Caplice, N. M., M. J. West, G. R. Campbell, and J. Campbell. Inhibition of human vascular smooth muscle cell growth by heparin. Lancet 344: 97-98, 1994.
5. Castellot, J. J., R. L. Hoover, P. A. Harper, and M. J. Karnovsky. Heparin and glomerular epithelial cell-secreted heparinlike species inhibit mesangial cell proliferation. Am. J. Pathol. 120: 427-435, 1985.
6. Chakrabarti, S., N. Ma, and A. A. F. Sima. Reduced number of anionic sites is associated with glomerular basement membrane thickening in the diabetic BB-rat. Diabetologia 32. 826-828, 1989
7. Christensen, C. K., and C. Ørskov. Rapid screening PEG radioimmunoassay for quantification of pathological microalbuminuria. Diabetic Nephrol. 3: 92-94, 1984.
8. Diamond, J. R., and M. J. Karnovsky. Non-anticoagulant protective effect of heparin in chronic aminonucleoside nephrosis. Renal Physiol. 9: 366-374, 1986.
9. Fager, G., G. Camejo, and G. Bondjers. The PDGF A-chain contains an amino acid sequence that specifically binds to heparin causing inactivation of the growth factor. Scand. J. Clin. Lab. Invest. 199: 33-36, 1990.
10. Floege, J., E. Eng, B. A. Young, W. G. Couser, and R. J. Johnson. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int. 43: 369-380, 1993.
11. Forrester, J. V., R. M. Knott, and L. C. McIntosh. Pathogenesis of proliferative diabetic retinopathy and maculopathy. In: The Diabetes Annual, edited by S. M. Marshall, P. D. Home, K. G. M. M. Alberti, and L. P. Krall. Amsterdam: Elsevier, 1993, vol. 7, p. 178-191.
12. Gambaro, G., A. O. Cavazzana, P. Luzi, A. Piccoli, A. Borsatti, G. Crepaldi, E. Marchi, A. P. Venturini, and B. Bagglo. Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int. 42: 285-291, 1992.
13. Gambaro, G., A. P. Venturini, D. M. Noonan, W. Fries, G. Re, S. Garbisa, C. Milanesi, A. Pesarini, A. Borsatti, and E. Marchi. Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. Kidney Int. 46: 797-806, 1994.
14. Groggel, G. C., G. N. Marinides, P. Hovingh, E. Hammond, and A. Linker. Inhibition of rat mesangial cell growth by heparan sulphate. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27): F259-F265, 1990.
15. Hirose, K., R. Østerby, M. Nozawa, and H. J. G. Gundersen. Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int. 21: 689-695, 1982.
16. Ichikawa, I., Y. Yosbida, A. Fogo, M. L. Purkerson, and S. Klahr. Effect of heparin on the glomerular structure and function of remnant nephrons. Kidney Int. 34: 638-644, 1988.
17. Kriz, W., E. Hackental, R. Nobling, T. Sakai, and M. Elger. A role for podocytes to counteract capillary wall distension. Kidney Int. 45: 369-376, 1994.
18. Makino, H., S. Ikeda, T. Haramoto, and Z. Ota. Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy. Nephron 61: 415-421, 1992.
19. Marinides, G. N., S. J. Suchard, and B. K. Mookerjee. Role of thrombospondin in mesangial cell growth: possible existence of an autocrine feedback growth circuit. Kidney Int. 46: 350-357, 1994.
20. Mauer, S. M., M. W. Steffes, E. N. Ellis, D. E. R. Sutherland, D. M. Brown, and F. C. Goetz. Structural-functional relationships in diabetic nephropathy. J. Clin. Invest. 74: 1143-1155, 1984.
21. Maunsbach, A. B. The influence of different fixatives and fixation methods on the ultrastructure of the rat kidney proximal tubule cells. II. Effects of varying osmolality, ionic strength, buffer system and fixative concentration of glutaraldehyde solutions. J. Ultrastruct. Res. 15: 283-309, 1966.
22. Mayhew, T. M., and A. Reith. Introducing basic principles and methods of stereology and morphometry. In: Problems and Solutions, edited by R. Reith and T. M. Mayhew. New York: Hemisphere, 1988, p. 1-12.
23. Myrup, B., P. M. Hansen, T. Jensen, A. Kofoed-Enevoldsen, B. Feldt-Rasmussen, J. Granff, C. Kluft, J. Jespersen, and T. Deckert. Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet 345: 421-422, 1995.
24. Nadar, H. B., V. Bounassisi, P. Colburn, and C. P. Dietrich. Heparin stimulates the synthesis and modifies the sulfation pattern of heparan sulfate proteoglycan from endothelial cells. J. Cell. Physiol. 140: 305-310, 1989.
25. Østerby, R. Glomerular structural changes in type 1 (insulin-dependent) diabetes. Consequences, causes and prevention. Diabetologia 35: 803-812, 1992.
26. Purkerson, M. L., D. M. Tollefsen, and S. Klahr. N-desulfated/ acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation. J. Clin. Invest. 81: 69-74, 1988.
27. Rohrbach, D. H., C. W. Wagner, V. L. Star, G. R. Martin, and K. S. Brown. Reduced synthesis of basement membrane heparan sulphate proteoglycan in streptozotocin diabetic mice. J. Biol. Chem. 258: 11672-11677, 1983.
28. Schimomura, H., and R. G. Spiro. Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes. Decreased levels of heparan sulphate proteoglycan and laminin. Diabetes 36: 374-381, 1987.
29. Tan, M.-S., J-C. Tsai, Y.-J. Lee, H.-C. Chen, S.-J. Shin, Y.-H. Lai, M. A. Perrella, C. Bianchi, S. Higashiyama, W. Endege, M.-U. Lee, and J.-H. Tsai. Induction of heparin-binding epidermal growth factor-like growth factor mRNA by protein kinase C activators. Kidney Int. 46: 690-695, 1994.
30. Wolthuis, A., A. Boes, J. H. M. Berden, and J. Grond. Heparins modulate extracellular matrix and protein synthesis of cultured rat mesangial cells. Virchows Arch. B Cell. Pathol. 63: 181-189, 1993.